Oncimmune (LON:ONC) Shares Down 11.7% – Here’s Why

Oncimmune Holdings plc (LON:ONC) was down 11.7% on Tuesday . The stock traded as low as GBX 12.50 ($0.15) and last traded at GBX 12.50 ($0.15). Approximately 250,390 shares traded hands during trading, an increase of 135% from the average daily volume of 106,670 shares. The stock had previously closed at GBX 14.15 ($0.17).

Oncimmune Stock Performance

The firm has a market capitalization of £9.64 million, a PE ratio of -433.33 and a beta of 1.19. The company has a debt-to-equity ratio of 806.85, a current ratio of 1.13 and a quick ratio of 0.63. The business has a 50-day simple moving average of GBX 15.05 and a 200-day simple moving average of GBX 14.65.

About Oncimmune

Oncimmune Holdings plc, an immunodiagnostics company, develops solutions for immuno-oncology, autoimmune disease and infectious diseases in the United Kingdom, North America, Europe, and internationally. It offers EarlyCDT-Lung, an immunodiagnostic blood test for detecting and identifying lung cancer; ImmunoINSIGHTS that enables life science organizations to optimize drug development and delivery; SeroTag discovery arrays for discovering and validating biomarkers for stratifying patients in multiple cancer indications, infectious diseases, and with various autoimmune diseases; and NavigAID, a disease-specific characterization panel.